Lista publicaţiilor: Zhang Qingling - 2

2018 - 1

Safety, tolerability, and pharmacokinetics of AL-335 in healthy volunteers and hepatitis C virus-infected subjects

McClure Matthew W. , Berliba Elina Tudor, Tsertsvadze Tengiz , Streinu-Cercel Adrian , Vijgen Leen , Astruc Beatrice , Patat Alain A. , Westland Christopher E. , Chanda Sushmita , Zhang Qingling , Kakuda Thomas , Vuong Jennifer , Khorlin Nick , Beigelman Leonid N. , Blatt Lawrence Mitchell , Fry John

1 Alios BioPharma, Inc., 2 ”Nicolae Testemițanu” State University of Medicine and Pharmacy, 3 AIDS and Clinical Immunology Research Center of Georgia, 4 University of Medicine and Pharmacy “Carol Davilla”, Bucharest, 5 Janssen Research & Development BE, Beerse, 6 Biotrial

PLoS ONE

Nr. 10(13) / 2018 / ISSN 1932-6203

Disponibil online 5 December, 2018

-----------------------------------------------------------------------------------------------------------------------------------

2013 - 1

ALS-2200, a novel once-daily nucleotide HCV polymerase inhibitor, demonstrates potent antiviral activity in treatmentnaıve GT1 chronic hepatitis C patients

Marcellin Patrick , Popa Sergiu , Berliba Elina Tudor, Boyer Nathalie , Streinu-Cercel Anca , Tong Myron , Kauffman Robert , Koziel Margaret , Chanda Sushmita , Zhang Qingling , Westland Christopher E. , Beigelman Leonid N. , Blatt Lawrence Mitchell , Fry John

1 Hopital Beaujon, 2 F.C.E. ARENSIA Exploratory Medicine, 3 "Professor Dr. Matei Balş" National Institute of Infectious Diseases, 4 Huntington Medical Research Institutes, Pasadena, CA, 5 Vertex Pharmaceuticals Inc, Cambridge, MA , 6 Alios BioPharma, Inc.

Hepatology International

Nr. S1(7) / 2013 / ISSN 1936-0533 / ISSNe 1936-0541

Disponibil online 17 December, 2021

-----------------------------------------------------------------------------------------------------------------------------------

10203040501005001000